Budesonide in the Management of Patients with Crohn’s Disease
Modern medical therapy is increasingly based on evidence. The evidence presented here is that budesonide (Entocort, Astra Pharma) 9 mg/day is superior to placebo and equivalent to systemically active glucocorticoster...
Gorde:
| Egile Nagusiak: | , , , |
|---|---|
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Wiley
1997-01-01
|
| Saila: | Canadian Journal of Gastroenterology |
| Sarrera elektronikoa: | http://dx.doi.org/10.1155/1997/271653 |
| Etiketak: |
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|